In addition, increasing evidence has identified macrophages as prominent effector cells and antibody‐dependent cell phagocytosis induction as a primary mechanism of action mediated by mAbs.41, 42, 43 Hence, potential synergistic anti‐tumor effects involving SIRPα targeting agents and tumor‐specific mAbs should be investigated in future experiments. This evidence concerns the gene SIRPA and neoplasm.